Report Detail
Global Cephalosporin Market Growth 2019-2024
- RnM3035040 |
- 27 February, 2019 |
- Global |
- 177 Pages |
- LPI(LP Information) |
- Pharma & Healthcare
Cephalosporin is an antibiotic medication commonly prescribed to treat several different types of infections.
The classification of Cephalosporin includes First Generation, Second Generation, Third Generation, Fourth Generation and the proportion of Third Generation in 2016 is about 37.2%, and the proportion is in increasing trend from 2012 to 2016.
China is the largest supplier of Cephalosporin, with a production market share nearly 43% in 2016. India is the second largest supplier of Cephalosporin, enjoying production market share nearly 22.3% in 2016.
Market competition is intense. Union Chempharma, NCPC, Qilu Antibiotics, Lupin Pharmaceuticals, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.
According to this study, over the next five years the Cephalosporin market will register a 2.0% CAGR in terms of revenue, the global market size will reach US$ 4140 million by 2024, from US$ 3690 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Cephalosporin business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Cephalosporin market by product type, application, key manufacturers and key regions and countries.
This study considers the Cephalosporin value and volume generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
First Generation
Second Generation
Third Generation
Fourth Generation
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Oral
Injection
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Union Chempharma
NCPC
Qilu Antibiotics
Lupin Pharmaceuticals
Hospira
Dhanuka Laboratories
Fukang
Dongying Pharmaceutical
Alkem
SALUBRIS
LIVZON
Hetero Drugs
CSPC
TEVA
Orchid Pharma
Taj Pharmaceuticals
Covalent Laboratories
United Laboratories
Aurobindo
Wockhardt
LKPC
HPGC
Huafangpharm
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Cephalosporin consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Cephalosporin market by identifying its various subsegments.
Focuses on the key global Cephalosporin manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Cephalosporin with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Cephalosporin submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
2019-2024 Global Cephalosporin Consumption Market Report
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Research Objectives
- 1.3 Years Considered
- 1.4 Market Research Methodology
- 1.5 Economic Indicators
- 1.6 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Cephalosporin Consumption 2014-2024
- 2.1.2 Cephalosporin Consumption CAGR by Region
- 2.2 Cephalosporin Segment by Type
- 2.2.1 First Generation
- 2.2.2 Second Generation
- 2.2.3 Third Generation
- 2.2.4 Fourth Generation
- 2.3 Cephalosporin Consumption by Type
- 2.3.1 Global Cephalosporin Consumption Market Share by Type (2014-2019)
- 2.3.2 Global Cephalosporin Revenue and Market Share by Type (2014-2019)
- 2.3.3 Global Cephalosporin Sale Price by Type (2014-2019)
- 2.4 Cephalosporin Segment by Application
- 2.4.1 Oral
- 2.4.2 Injection
- 2.5 Cephalosporin Consumption by Application
- 2.5.1 Global Cephalosporin Consumption Market Share by Application (2014-2019)
- 2.5.2 Global Cephalosporin Value and Market Share by Application (2014-2019)
- 2.5.3 Global Cephalosporin Sale Price by Application (2014-2019)
3 Global Cephalosporin by Players
- 3.1 Global Cephalosporin Sales Market Share by Players
- 3.1.1 Global Cephalosporin Sales by Players (2017-2019)
- 3.1.2 Global Cephalosporin Sales Market Share by Players (2017-2019)
- 3.2 Global Cephalosporin Revenue Market Share by Players
- 3.2.1 Global Cephalosporin Revenue by Players (2017-2019)
- 3.2.2 Global Cephalosporin Revenue Market Share by Players (2017-2019)
- 3.3 Global Cephalosporin Sale Price by Players
- 3.4 Global Cephalosporin Manufacturing Base Distribution, Sales Area, Product Types by Players
- 3.4.1 Global Cephalosporin Manufacturing Base Distribution and Sales Area by Players
- 3.4.2 Players Cephalosporin Products Offered
- 3.5 Market Concentration Rate Analysis
- 3.5.1 Competition Landscape Analysis
- 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
- 3.6 New Products and Potential Entrants
- 3.7 Mergers & Acquisitions, Expansion
4 Cephalosporin by Regions
- 4.1 Cephalosporin by Regions
- 4.1.1 Global Cephalosporin Consumption by Regions
- 4.1.2 Global Cephalosporin Value by Regions
- 4.2 Americas Cephalosporin Consumption Growth
- 4.3 APAC Cephalosporin Consumption Growth
- 4.4 Europe Cephalosporin Consumption Growth
- 4.5 Middle East & Africa Cephalosporin Consumption Growth
5 Americas
- 5.1 Americas Cephalosporin Consumption by Countries
- 5.1.1 Americas Cephalosporin Consumption by Countries (2014-2019)
- 5.1.2 Americas Cephalosporin Value by Countries (2014-2019)
- 5.2 Americas Cephalosporin Consumption by Type
- 5.3 Americas Cephalosporin Consumption by Application
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Key Economic Indicators of Few Americas Countries
6 APAC
- 6.1 APAC Cephalosporin Consumption by Countries
- 6.1.1 APAC Cephalosporin Consumption by Countries (2014-2019)
- 6.1.2 APAC Cephalosporin Value by Countries (2014-2019)
- 6.2 APAC Cephalosporin Consumption by Type
- 6.3 APAC Cephalosporin Consumption by Application
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 6.10 Key Economic Indicators of Few APAC Countries
7 Europe
- 7.1 Europe Cephalosporin by Countries
- 7.1.1 Europe Cephalosporin Consumption by Countries (2014-2019)
- 7.1.2 Europe Cephalosporin Value by Countries (2014-2019)
- 7.2 Europe Cephalosporin Consumption by Type
- 7.3 Europe Cephalosporin Consumption by Application
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
- 7.9 Spain
- 7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
- 8.1 Middle East & Africa Cephalosporin by Countries
- 8.1.1 Middle East & Africa Cephalosporin Consumption by Countries (2014-2019)
- 8.1.2 Middle East & Africa Cephalosporin Value by Countries (2014-2019)
- 8.2 Middle East & Africa Cephalosporin Consumption by Type
- 8.3 Middle East & Africa Cephalosporin Consumption by Application
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers and Impact
- 9.1.1 Growing Demand from Key Regions
- 9.1.2 Growing Demand from Key Applications and Potential Industries
- 9.2 Market Challenges and Impact
- 9.3 Market Trends
10 Marketing, Distributors and Customer
- 10.1 Sales Channel
- 10.1.1 Direct Channels
- 10.1.2 Indirect Channels
- 10.2 Cephalosporin Distributors
- 10.3 Cephalosporin Customer
11 Global Cephalosporin Market Forecast
- 11.1 Global Cephalosporin Consumption Forecast (2019-2024)
- 11.2 Global Cephalosporin Forecast by Regions
- 11.2.1 Global Cephalosporin Forecast by Regions (2019-2024)
- 11.2.2 Global Cephalosporin Value Forecast by Regions (2019-2024)
- 11.2.3 Americas Consumption Forecast
- 11.2.4 APAC Consumption Forecast
- 11.2.5 Europe Consumption Forecast
- 11.2.6 Middle East & Africa Consumption Forecast
- 11.3 Americas Forecast by Countries
- 11.3.1 United States Market Forecast
- 11.3.2 Canada Market Forecast
- 11.3.3 Mexico Market Forecast
- 11.3.4 Brazil Market Forecast
- 11.4 APAC Forecast by Countries
- 11.4.1 China Market Forecast
- 11.4.2 Japan Market Forecast
- 11.4.3 Korea Market Forecast
- 11.4.4 Southeast Asia Market Forecast
- 11.4.5 India Market Forecast
- 11.4.6 Australia Market Forecast
- 11.5 Europe Forecast by Countries
- 11.5.1 Germany Market Forecast
- 11.5.2 France Market Forecast
- 11.5.3 UK Market Forecast
- 11.5.4 Italy Market Forecast
- 11.5.5 Russia Market Forecast
- 11.5.6 Spain Market Forecast
- 11.6 Middle East & Africa Forecast by Countries
- 11.6.1 Egypt Market Forecast
- 11.6.2 South Africa Market Forecast
- 11.6.3 Israel Market Forecast
- 11.6.4 Turkey Market Forecast
- 11.6.5 GCC Countries Market Forecast
- 11.7 Global Cephalosporin Forecast by Type
- 11.8 Global Cephalosporin Forecast by Application
12 Key Players Analysis
- 12.1 Union Chempharma
- 12.1.1 Company Details
- 12.1.2 Cephalosporin Product Offered
- 12.1.3 Union Chempharma Cephalosporin Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.1.4 Main Business Overview
- 12.1.5 Union Chempharma News
- 12.2 NCPC
- 12.2.1 Company Details
- 12.2.2 Cephalosporin Product Offered
- 12.2.3 NCPC Cephalosporin Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.2.4 Main Business Overview
- 12.2.5 NCPC News
- 12.3 Qilu Antibiotics
- 12.3.1 Company Details
- 12.3.2 Cephalosporin Product Offered
- 12.3.3 Qilu Antibiotics Cephalosporin Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.3.4 Main Business Overview
- 12.3.5 Qilu Antibiotics News
- 12.4 Lupin Pharmaceuticals
- 12.4.1 Company Details
- 12.4.2 Cephalosporin Product Offered
- 12.4.3 Lupin Pharmaceuticals Cephalosporin Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.4.4 Main Business Overview
- 12.4.5 Lupin Pharmaceuticals News
- 12.5 Hospira
- 12.5.1 Company Details
- 12.5.2 Cephalosporin Product Offered
- 12.5.3 Hospira Cephalosporin Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.5.4 Main Business Overview
- 12.5.5 Hospira News
- 12.6 Dhanuka Laboratories
- 12.6.1 Company Details
- 12.6.2 Cephalosporin Product Offered
- 12.6.3 Dhanuka Laboratories Cephalosporin Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.6.4 Main Business Overview
- 12.6.5 Dhanuka Laboratories News
- 12.7 Fukang
- 12.7.1 Company Details
- 12.7.2 Cephalosporin Product Offered
- 12.7.3 Fukang Cephalosporin Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.7.4 Main Business Overview
- 12.7.5 Fukang News
- 12.8 Dongying Pharmaceutical
- 12.8.1 Company Details
- 12.8.2 Cephalosporin Product Offered
- 12.8.3 Dongying Pharmaceutical Cephalosporin Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.8.4 Main Business Overview
- 12.8.5 Dongying Pharmaceutical News
- 12.9 Alkem
- 12.9.1 Company Details
- 12.9.2 Cephalosporin Product Offered
- 12.9.3 Alkem Cephalosporin Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.9.4 Main Business Overview
- 12.9.5 Alkem News
- 12.10 SALUBRIS
- 12.10.1 Company Details
- 12.10.2 Cephalosporin Product Offered
- 12.10.3 SALUBRIS Cephalosporin Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.10.4 Main Business Overview
- 12.10.5 SALUBRIS News
- 12.11 LIVZON
- 12.12 Hetero Drugs
- 12.13 CSPC
- 12.14 TEVA
- 12.15 Orchid Pharma
- 12.16 Taj Pharmaceuticals
- 12.17 Covalent Laboratories
- 12.18 United Laboratories
- 12.19 Aurobindo
- 12.20 Wockhardt
- 12.21 LKPC
- 12.22 HPGC
- 12.23 Huafangpharm
13 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Cephalosporin . Industry analysis & Market Report on Cephalosporin is a syndicated market report, published as Global Cephalosporin Market Growth 2019-2024. It is complete Research Study and Industry Analysis of Cephalosporin market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
